Vitafol Fe Plus Capsule, Liquid Filled
NDC Package 0642-7473-30
Package Information
Vitafol Fe Plus (doconexent, niacinamide, .alpha.-tocopherol acetate, dl-, cholecalciferol, beta carotene, ascorbic acid, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, iron, zinc oxide, cupric oxide, potassium iodide, magnesium oxide, folic acid, and levomefolate calcium) capsules is vitafol® Fe+ prenatal supplement is contraindicated in patients with hypersensitivity to any of its components or color additives.Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.Iron supplementation is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver.Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin B12). This formulation utilizes a capsule, liquid filled delivery system. Marketed by Exeltis Usa, Inc., this product is identified by NDC 0642-7473.
Identification & Billing
Clinical Specifications
- .ALPHA.-TOCOPHEROL ACETATE, DL- 9 mg/1
- ASCORBIC ACID 60 mg/1
- BETA CAROTENE 330 ug/1
- CHOLECALCIFEROL 25 mg/1
- CUPRIC OXIDE 2 mg/1
- CYANOCOBALAMIN 25 ug/1
- DOCONEXENT 200 mg/1
- FOLIC ACID 680 mg/1
- IRON 90 mg/1
- LEVOMEFOLATE CALCIUM 1020 ug/1
- MAGNESIUM OXIDE 20 mg/1
- NIACINAMIDE 15 mg/1
- POTASSIUM IODIDE 150 ug/1
- PYRIDOXINE HYDROCHLORIDE 2.5 mg/1
- RIBOFLAVIN 1.8 mg/1
- THIAMINE MONONITRATE 1.6 mg/1
- ZINC OXIDE 25 mg/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Folate Analog - [EPC] (Established Pharmacologic Class)
- Folic Acid - [CS]
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0642 - Exeltis Usa, Inc.
- 0642-7473 - Vitafol Fe Plus
- 0642-7473-30 - 5 BLISTER PACK in 1 BOX, UNIT-DOSE / 6 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
- 0642-7473 - Vitafol Fe Plus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0642-7473-30 identifies a specific commercial package of 5 blister pack in 1 box, unit-dose / 6 capsule, liquid filled in 1 blister pack of Vitafol Fe Plus, a human prescription drug labeled by Exeltis Usa, Inc.. This capsule, liquid filled is formulated for oral use and contains .alpha.-tocopherol acetate, dl-; ascorbic acid; beta carotene; cholecalciferol; cupric oxide; cyanocobalamin; doconexent; folic acid; iron; levomefolate calcium; magnesium oxide; niacinamide; potassium iodide; pyridoxine hydrochloride; riboflavin; thiamine mononitrate; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Exeltis Usa, Inc. on March 15, 2020. The current certification is valid through December 31, 2026.
How is this Exeltis Usa, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00642747330. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.